当前位置: 首页 > 期刊 > 《中国健康月刊·A版》 > 2011年第10期 > 正文
编号:12156749
2型糖尿病合并冠心病患者血清内脂素水平的研究(1)
http://www.100md.com 2011年10月1日 崔庆日 张辉 郑光波
第1页

    参见附件(4359KB,3页)。

     [摘要] 目的 探讨血清内脂素在2型糖尿病合并冠心病、冠心病及2型糖尿病患者中的作用。方法 采用酶联免疫法(ELISA)对临床上确诊为2型糖尿病合并冠心病患者72例,冠心病患者105例,2型糖尿病患者85例及健康对照组30例,进行血清内脂素水平的测定。结果 2型糖尿病合并冠心病组、冠心病组及2型糖尿病组的血清内脂素水平明显高于健康对照组(P﹤0.01),2型糖尿病合并冠心病组血清内脂素水平高于冠心病组和2型糖尿病组(P﹤0.01),均有统计学意义。结论 血清内脂素在2型糖尿病和冠心病的发生和发展中均具有一定的生理作用,但2型糖尿病合并冠心病组的血清内脂素水平较冠心病组和2型糖尿病组高其生物学机理有待进一步研究。

    [关键词] 2型糖尿病合并冠心病; 内脂素; 冠心病; 2型糖尿病

    [中图分类号] R54[文献标识码] B[文章编号] 1005-0515(2011)-08-001-02

    Study on Serum Visfatin Level in Patients with Type 2 Diabetes Mellitus combined with coronary Disease

    Cui Qingri1Zhang Hui2Zheng Guangbo3

    (1Anyang Sixth People's Hospital Department of Cardiovascular Internal Medicine,Henan Anyang,455000,2The Second Hospital of Hebei Medical University cardiology,Hebei Shijiazhuang,050000,3Shijiazhang Jizhong Energy Well Mine Jingxing Mining General Hospital Internal Medicine,Hebei Shijiazhuang,050100)

    [Abstract] Objective To investigate the change of serum visfatin level in patients with coronary disease and coronary diaease complicated with type 2 diabetes mellitus and type 2 diabetes mellitus.Methods The serum lipid levels in 4 groups were assayed by ELISA.72 cases with coronary disease complicated with type 2 diabetes mellitus,105 cases with coronary disease,85 cases with type 2 diaetes mellitus,and 30 control cases were studied.Results The serum lipid level in patients with type 2 diabetes mellitus combined with coronary disease and patients with coronary disease and patients with type 2 diabetes mellitus were significantly higher than in controls(P﹤0.01).The serum lipid level in patients with type 2 diabetes mellitus combined with coronary disease were higher than the patients with coronary disease and the patients with type 2 diabetes mellitus(P﹤0.01).All have statistically significant.Conlusion The serum lipid may contribute to the pathogenesis of type 2 diabetes mellitus and coronary disease, However, type 2 diabetes with coronary heart disease in the serum lipid levels than CHD and type 2 diabetes group at the biological mechanism needs further study ......

您现在查看是摘要介绍页,详见PDF附件(4359KB,3页)